Shares of Australian medical cannabis firm ECS Botanics (ASX:ECS) rose by as much as 8.3% to A$0.026, marking the largest intraday percentage gain since October 3rd.

The company has reported 106,000 units of medicinal cannabis oils ordered during the September quarter, which is a record figure.

ECS Botanics also noted that they are experiencing a particularly sharp increase in demand for their medicinal cannabis oils, signaling potentially sustained growth in this market niche.

Their quarterly revenue reached A$4.1 million, an increase of 78%, resulting in a positive net operating cash flow for the quarter.

Despite volatility, ECS Botanics has seen a 20% increase in their shares this year up to their last closing.

ECS Botanics is an Australian company that develops, produces and sells medicinal cannabis oils.